16% of the top 100 pharmaceutical drugs and 35% of biologic drugs are lyophilized. With more than 30% of the FDA-approved parenterals lyophilized and soon more than half injectable drugs to require lyophilization there is ample room for standardization and expansion of the lyophilization process in pharmaceuticals.

However, lyophilization is one of the most time consuming and expensive unit operations. There are many issues within lyopilization which need addressing, and improved drying technologies are needed for current and future products.

Join us this November 2018, as we look toward the future of lyophilization. Network with industry experts, discuss regulatory challenges and unmet needs within lyophilization, gain insights into innovative technologies and strategies to challenges within freeze-drying, discover new methods of scale-up and technology transfer, and explore alternative processes beyond conventional lyophilization.

Exclusive offer: save 200$ on your registration with voucher code P269JQ200